Merck & Co., Inc.
MRK
$92.65
-$0.54-0.58%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 17.12B | 12.15B | 13.74B | 2.31B | 365.00M |
Total Depreciation and Amortization | 4.25B | 4.03B | 3.87B | 3.68B | 3.73B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 3.77B | 3.75B | 1.16B | 11.47B | 11.11B |
Change in Net Operating Assets | -3.67B | -1.67B | -2.07B | -2.70B | -2.21B |
Cash from Operations | 21.47B | 18.26B | 16.69B | 14.76B | 13.01B |
Capital Expenditure | -3.37B | -3.42B | -3.54B | -3.72B | -3.86B |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -4.09B | -4.09B | -746.00M | -11.45B | -12.03B |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -269.00M | 1.28B | 1.56B | 2.07B | 1.81B |
Cash from Investing | -7.73B | -6.24B | -2.73B | -13.10B | -14.08B |
Total Debt Issued | 3.60B | 3.60B | 1.66B | 5.94B | 5.94B |
Total Debt Repaid | -1.29B | -754.00M | -755.00M | -2.51B | -1.76B |
Issuance of Common Stock | 177.00M | 171.00M | 173.00M | 182.00M | 125.00M |
Repurchase of Common Stock | -1.31B | -1.21B | -1.23B | -1.32B | -1.35B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -7.84B | -7.74B | -7.64B | -7.54B | -7.45B |
Other Financing Activities | -372.00M | -333.00M | -311.00M | -325.00M | -328.00M |
Cash from Financing | -7.03B | -6.27B | -8.11B | -5.57B | -4.81B |
Foreign Exchange rate Adjustments | -293.00M | 260.00M | -191.00M | -202.00M | 23.00M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 6.41B | 6.02B | 5.66B | -4.12B | -5.86B |